Acelyrin, Inc. (NASDAQ: SLRN)
$2.0300
-0.0700 ( -5.58% ) 549.0K
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
Market Data
Open
$2.0300
Previous close
$2.1000
Volume
549.0K
Market cap
$203.66M
Day range
$2.0210 - $2.1610
52 week range
$1.9100 - $8.8850
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 2 | May 17, 2024 |
| 10-q | Quarterly Reports | 74 | May 14, 2024 |
| 8-k | 8K-related | 16 | May 09, 2024 |
| ars | Annual reports | 1 | Apr 22, 2024 |
| def | Proxies and info statements | 3 | Apr 22, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 10-k | Annual reports | 104 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 20, 2024 |
| 8-k | 8K-related | 48 | Mar 11, 2024 |